Neurotech’s NT-501 Implant Slows Vision Loss In Patients With Geographic Atrophy Associated With Dry AMD As Reported In PNAS

Neurotech Pharmaceuticals, Inc., today announced that it was reported in the Proceedings of the National Academy of Sciences (PNAS) (online March 28, 2011) that its product candidate NT-501 slowed progression of vision loss in patients with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD) in a Phase 2 study...